Bio-Rad is at the forefront of antibody development, leveraging cutting-edge technologies and expertise to address critical challenges in the field. Bio-Rad’s antibody services including HuCAL TM ...

Phage display remains the most widely used antibody discovery method owing to its versatility, robustness, applicability, and ...

Naturally, the pharma industry has seen an explosion of mAbs in the pipeline, which has led to the evolution of new methods for improving and refining the antibody pipeline. Artificial ...

Abcellera, for example, designed Lily’s COVID antibody ... business of drug discovery, find promising targets, and then sell them to pharma to carry out the expensive process of development ...

Professor of Health Sciences Newman Sze and his international team have identified a specific antibody that targets ... fueling the aging process and age-related chronic diseases.

Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its ...

With the advent of artificial intelligence (AI), the industry witnessed a rapid transformation in early disease detection, genomic research, drug discovery, clinical processes, and treatment ...

Invenra will leverage its B-Body® bispecific antibody platform from monoclonal antibody discovery to optimized panels of bispecific leads. Orion will be responsible for the selection of targets ...